Triazole derivatives and their use as peroxisome proliferator activated receptor alpha agonists
Details for Australian Patent Application No. 2002228592 (hide)
International Classifications
Event Publications
27 April 2006 Application Accepted
Published as AU-B-2002228592
24 August 2006 Standard Patent Sealed
24 August 2006 Corrigenda
Applications Accepted - Name Index Under the name Eli Lilly and Company, Application No. 2002228592, under INID (72) correct the co-inventor to read Letourneau, Michael Edward.
3 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser